Schedule 13D ownership disclosure
Innoviva Inc
Security class unavailable · CUSIP: 45781M101
Event date: 2017-04-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 32,005,260
- Percent of class
- 29.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898822-17-000046
- Form type
- SC 13D
- Filer
- GSK plc
- CIK
- CIK 1131399
- Filed
- Apr 13, 2017
- Reporting period
- Apr 13, 2017
- Description
- Schedule 13D beneficial ownership